EE200000646A - Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid - Google Patents

Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid

Info

Publication number: EE200000646A
Authority: EE; Estonia
Prior art keywords: lamivudine; zidovudine; pharmaceutical compositions; compositions containing; homogeneous pharmaceutical
Prior art date: 1998-04-29

Application number

EEP200000646A

Other languages

English (en)

Estonian (et)

Inventor

Wayne Wood Allen

Currie Robin

Jain Sunil

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-29

Filing date

1999-04-26

Publication date

2002-04-15

1999-04-26 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2002-04-15 Publication of EE200000646A publication Critical patent/EE200000646A/xx

Links

LHCOVOKZWQYODM-CPEOKENHSA-N 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1.O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 LHCOVOKZWQYODM-CPEOKENHSA-N 0.000 title 1
229960004748 abacavir Drugs 0.000 title 1
MCGSCOLBFJQGHM-SCZZXKLOSA-N abacavir Chemical compound C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 MCGSCOLBFJQGHM-SCZZXKLOSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Biophysics (AREA)
AIDS & HIV (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EEP200000646A 1998-04-29 1999-04-26 Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid EE200000646A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9809213.3A GB9809213D0 (en)	1998-04-29	1998-04-29	Pharmaceutical compositions
PCT/EP1999/002794 WO1999055372A1 (en)	1998-04-29	1999-04-26	Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine

Publications (1)

Publication Number	Publication Date
EE200000646A true EE200000646A (et)	2002-04-15

Family

ID=10831228

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200000646A EE200000646A (et)	1998-04-29	1999-04-26	Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid

Country Status (23)

Country	Link
EP (1)	EP1083932A1 (xx)
JP (1)	JP2002512979A (xx)
KR (1)	KR20010043128A (xx)
CN (1)	CN1411380A (xx)
AP (1)	AP2000001971A0 (xx)
AU (1)	AU4135599A (xx)
BR (1)	BR9910071A (xx)
CA (1)	CA2330391A1 (xx)
EA (1)	EA200000997A1 (xx)
EE (1)	EE200000646A (xx)
GB (1)	GB9809213D0 (xx)
HR (1)	HRP20000732A2 (xx)
HU (1)	HUP0101622A3 (xx)
ID (1)	ID26955A (xx)
IL (1)	IL139181A0 (xx)
IS (1)	IS5675A (xx)
NO (1)	NO20005418L (xx)
NZ (1)	NZ507745A (xx)
PL (1)	PL343710A1 (xx)
SK (1)	SK16212000A3 (xx)
TR (1)	TR200003157T2 (xx)
WO (1)	WO1999055372A1 (xx)
ZA (1)	ZA200005922B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6875773B1 (en)	1998-05-29	2005-04-05	Ben M. Dunn	Combination therapy for treatment of FIV infection
CA2374198A1 (en) *	1998-05-29	1999-12-02	Maki Arai	Combination therapy for treatment of fiv infection
GB9820417D0 (en) *	1998-09-18	1998-11-11	Glaxo Group Ltd	Antiviral combinations
US7074417B2 (en) *	2000-10-13	2006-07-11	Advancis Pharmaceutical Corporation	Multiple-delayed release anti-viral product, use and formulation thereof
DE60219965T2 (de) *	2002-04-23	2008-01-17	Lupin Ltd., Mumbai	Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
TW200403061A (en) *	2002-06-04	2004-03-01	Glaxo Group Ltd	Pharmaceutical compositions
CN100335125C (zh) *	2003-06-03	2007-09-05	上海现代药物制剂工程研究中心	杀毒抗菌用长效干扰素喷鼻粉剂
WO2006114709A1 (en) *	2005-04-25	2006-11-02	Aurobindo Pharma Limited	Pharmaceutical compositions of antiretrovirals
WO2007013047A2 (en) *	2005-07-29	2007-02-01	Ranbaxy Laboratories Limited	Water-dispersible anti-retroviral pharmaceutical compositions
ES2279707B1 (es) *	2005-11-10	2008-06-01	Combino Pharm, S.L.	Formulaciones orales que comprenden 3'-azidonucleosidos.
US20110053884A1 (en) *	2007-10-02	2011-03-03	Schinazi Raymond F	Potent combinations of zidovudine and drugs that select for the k65r mutation in the hiv polymerase
GB2470494B (en) *	2008-01-17	2012-08-08	Univ Holy Ghost Duquesne	Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS
PH12012501537A1 (en) *	2010-01-27	2018-02-07	Viiv Healthcare Co	Antiviral therapy
CN114010776A (zh)	2010-06-09	2022-02-08	疫苗技术股份有限公司	用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
EP2822560A1 (en)	2012-03-05	2015-01-14	Cipla Limited	Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
CN104884063A (zh)	2012-10-23	2015-09-02	西普拉有限公司	抗逆转录病毒药物组合物
EP3007695B1 (en)	2013-06-13	2024-02-07	Akebia Therapeutics, Inc.	Compositions and methods for treating anemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY115461A (en) *	1995-03-30	2003-06-30	Wellcome Found	Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9622681D0 (en) *	1996-10-31	1997-01-08	Glaxo Group Ltd	Pharmaceutical compositions

1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
1999
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/ja active Pending
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/sk unknown
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/ko not_active Withdrawn
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Ceased
- 1999-04-26 HR HR20000732A patent/HRP20000732A2/hr not_active Application Discontinuation
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 ID IDW20002479A patent/ID26955A/id unknown
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 IL IL13918199A patent/IL139181A0/xx unknown
- 1999-04-26 EE EEP200000646A patent/EE200000646A/xx unknown
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 CN CN99807983A patent/CN1411380A/zh active Pending
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/pt not_active IP Right Cessation
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/xx unknown
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/hu unknown
- 1999-04-26 PL PL99343710A patent/PL343710A1/xx unknown
- 1999-04-26 EA EA200000997A patent/EA200000997A1/ru unknown
2000
- 2000-10-20 IS IS5675A patent/IS5675A/is unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/xx unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20010043128A (ko)	2001-05-25
NO20005418L (no)	2000-11-29
PL343710A1 (en)	2001-08-27
CN1411380A (zh)	2003-04-16
NO20005418D0 (no)	2000-10-27
ZA200005922B (en)	2001-10-23
EP1083932A1 (en)	2001-03-21
AU4135599A (en)	1999-11-16
HUP0101622A2 (hu)	2002-03-28
GB9809213D0 (en)	1998-07-01
IS5675A (is)	2000-10-20
EA200000997A1 (ru)	2001-06-25
BR9910071A (pt)	2000-12-26
WO1999055372A1 (en)	1999-11-04
TR200003157T2 (tr)	2001-01-22
ID26955A (id)	2001-02-22
NZ507745A (en)	2004-07-30
JP2002512979A (ja)	2002-05-08
IL139181A0 (en)	2001-11-25
HRP20000732A2 (en)	2001-02-28
CA2330391A1 (en)	1999-11-04
HUP0101622A3 (en)	2003-09-29
SK16212000A3 (sk)	2001-07-10
AP2000001971A0 (en)	2000-12-31

Publication	Publication Date	Title
DE69924999D1 (de)	2005-06-02	Lipasehemmer enthaltende pharmazeutische zusammensetzungen
EE200000646A (et)	2002-04-15	Abakaviiri, lamivudiini ja zidovudiini sisaldavadhomogeensed farmatseutilised kompositsioonid
ID26982A (id)	2001-02-22	Komposisi farmasi topiramat
BR9913138B1 (pt)	2013-11-05	Derivado de quinolin-2-ona substituído com alquinila e composição farcêutica contendo o mesmo
EE200000468A (et)	2002-04-15	Ühendid, nende kasutamine ja farmatseutiline kompositsioon
ID22981A (id)	1999-12-23	Komposisi pengelantang
ID21491A (id)	1999-06-17	Komposisi aerosol farmasi
ATE228357T1 (de)	2002-12-15	Nukleotid-analoge zusammensetzung
DK1139739T3 (da)	2003-01-20	Agrokemiske præparater
DE69903248D1 (de)	2002-11-07	Leitfähige zusammensetzung
NO20006520L (no)	2001-02-14	Adenosinderivater
DK1112266T3 (da)	2003-09-15	Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
EE200000621A (et)	2002-06-17	Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine
DK1466615T3 (da)	2009-08-31	Farmaceutisk præparat
DE69900561D1 (de)	2002-01-24	Pharmazeutische Zusammensetzungen enthaltend Mupirocin
ID17774A (id)	1998-01-29	Komposisi farmasi antitrombosis
DE59911148D1 (de)	2004-12-30	Propoxilat enthaltende kraftstoffzusammensetzungen
PT1140808E (pt)	2005-04-29	Formulacoes de pesticidas contendo tensioactivos de ester de hemissulfato de tristirilfenol alcoxilado, neutralizados com amina alcoxilada
DE69936800D1 (de)	2007-09-20	Massenspektrometer
ITMI982222A0 (it)	1998-10-16	Composizioni farmaceutiche orali contenenti buprenorfina
DE59801987D1 (de)	2001-12-06	Pharmazeutische zusammensetzung enthaltend peptichemio
EE9900175A (et)	1999-12-15	Lamivudiini ja sidovudiini sisaldavad farmatseutilised kompositsioonid
PT1227817E (pt)	2004-11-30	Composicao farmaceutica aquosa contendo ciclesonida
IT1298731B1 (it)	2000-02-02	Composizioni farmaceutiche contenenti complessi di inclusione con melatonina
EP1124557A4 (en)	2002-08-07	Pharmaceutical composition